PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ginkgo Biloba→

Ginkgo Biloba PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
90028-76-5
Molecular formula
Not available
Molecular weight
Not available
Drug class
Botanical extractflavonoid and terpene-lactone phytopharmaceutical
Mechanism of action
Standardised Ginkgo biloba leaf extracts contain flavonoid glycosides and terpene lactones, including ginkgolides and bilobalide. Proposed activities include antioxidant effects, modulation of platelet-activating factor, microcirculatory effects and neuroprotective signalling. Composition and pharmacology are extract-specific.
Indications / reported uses
  • Certain standardised Ginkgo biloba extracts are authorised or licensed in some countries for symptomatic treatment of mild cognitive impairment or age-related cognitive symptoms, and/or support of peripheral circulation. Uses cannot be generalised to all Ginkgo preparations or dietary supplements.

Sources: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=ginkgo.biloba2&lang=eng · https://pmc.ncbi.nlm.nih.gov/articles/PMC6488894/ · https://www.ncbi.nlm.nih.gov/books/NBK541024/

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ginkgo Biloba PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ginkgo Biloba Permitted Daily Exposure (PDE) report (the Ginkgo Biloba PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ginkgo Biloba Occupational Exposure Limit (OEL) report (the Ginkgo Biloba OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.